Carbachol ameliorates lipopolysaccharide-induced intestinal epithelial tight junction damage by down-regulating NF-κβ and myosin light-chain kinase pathways

Biochemical and Biophysical Research Communications

Volumn 428, Issue 2, 2012, Pages 321-326

  Zhang, Ying ^a   Li, Jianguo ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Carbachol; Intestinal permeability; Myosin light chain kinase; Nuclear factor kappa beta; Tight junction

Indexed keywords

ALPHA BUNGAROTOXIN; CARBACHOL; CLAUDIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MYOSIN LIGHT CHAIN KINASE; PROTEIN ZO1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; INTESTINAL EPITHELIAL TIGHT JUNCTION DAMAGE; INTESTINE EPITHELIUM; INTESTINE INJURY; MALE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; TIGHT JUNCTION;

ANIMALS; CARBACHOL; CHOLINERGIC AGONISTS; CYTOPROTECTION; DOWN-REGULATION; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; MYOSIN-LIGHT-CHAIN KINASE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

RATTUS;

EID: 84869239536     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.056     Document Type: Article

References (31)

1. Shinozaki S., Inoue Y., Yang W., Fukaya M., Carter E.A., Yu Y.M., Fischman A., Tompkins R., Kaneki M. Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice. Biochem. Biophys. Res. Commun. 2010, 391:1459-1464.
2. De-Souza D.A., Greene L.J. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit. Care Med. 2005, 33:1125-1135.
3. Doig C.J., Sutherland L.R., Sandham J.D., Fick G.H., Verhoef M., Meddings J.B. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am. J. Respir. Crit. Care Med. 1998, 158:444-451.
4. Madara J.L. Warner-Lambert/Parke-Davis Award lecture. Pathobiology of the intestinal epithelial barrier. Am. J. Pathol. 1990, 137:1273-1281.
5. Stevenson B.R., Siliciano J.D., Mooseker M.S., Goodenough D.A. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J. Cell Biol. 1986, 103:755-766.
6. Furuse M., Sasaki H., Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J. Cell Biol. 1999, 147:891-903.
7. Li Q., Zhang Q., Wang C., Liu X., Li N., Li J. Disruption of tight junctions during polymicrobial sepsis in vivo. J. Pathol. 2009, 218:210-221.
8. Turner J.R. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am. J. Pathol. 2006, 169:1901-1909.
9. Moriez R., Salvador-Cartier C., Theodorou V., Fioramonti J., Eutamene H., Bueno L. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. Am. J. Pathol. 2005, 167:1071-1079.
10. Ye D., Ma I., Ma T.Y. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G496-504.
11. Gu L., Li N., Gong J., Li Q., Zhu W., Li J. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J. Infect. Dis. 2011, 203:1602-1612.
12. Costantini T.W., Loomis W.H., Putnam J.G., Kroll L., Eliceiri B.P., Baird A., Bansal V., Coimbra R. Pentoxifylline modulates intestinal tight junction signaling after burn injury: effects on myosin light chain kinase. J. Trauma 2009, 66:17-24. (discussion 24-15).
13. Hu S., Jiang X.G., Shi D.G., Lu Y., Li J.Y., Sun D., Sheng Z.Y. Carbachol alleviates inflammation in gut tissue during ischemia/reperfusion in rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2003, 15:748-750.
14. Hu S., Zhang L.J., Bai H.Y., Bao C.M. The protective effects of carbachol on visceral ischemia-induced lipid peroxidation injury in rats with sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2009, 21:552-554.
15. Hu S., Zou X.F., Lu Y., Lu J.Y., Sheng Z.Y. Effects of carbachol on apoptosis of intestinal epithelial cells after gut ischemia/reperfusion in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007, 19:463-466.
16. Zhou G., Hu S., Lv Y., Song Q., Zou X., Sheng Z. Carbachol alleviates rat cytokine release and organ dysfunction induced by lipopolysaccharide. J. Trauma 2011, 71:157-162.
17. Cao W.H., Chai J.K., Hu S., Yang H.M., Sun T.J., Zou X.F., Sheng Z.Y. Influence of carbachol on intestinal dysfunction after traumatic or burn injury. Zhonghua Shao Shang Za Zhi 2006, 22:168-171.
18. Chiu C.J., McArdle A.H., Brown R., Scott H.J., Gurd F.N. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch. Surg. 1970, 101:478-483.
19. Song X.M., Li J.G., Wang Y.L., Hu Z.F., Zhou Q., Du Z.H., Jia B.H. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats. Shock 2008, 30:468-472.
20. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991, 19:2499.
21. Li H.M., Wang Y.Y., Wang H.D., Cao W.J., Yu X.H., Lu D.X., Qi R.B., Hu C.F., Yan Y.X. Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms. Acta Pharmacol. Sin. 2011, 32:1364-1372.
22. Chin A.C., Flynn A.N., Fedwick J.P., Buret A.G. The role of caspase-3 in lipopolysaccharide-mediated disruption of intestinal epithelial tight junctions. Can. J. Physiol. Pharmacol. 2006, 84:1043-1050.
23. Krzyzaniak M., Peterson C., Loomis W., Hageny A.M., Wolf P., Reys L., Putnam J., Eliceiri B., Baird A., Bansal V., Coimbra R. Postinjury vagal nerve stimulation protects against intestinal epithelial barrier breakdown. J. Trauma 2011, 70:1168-1175. (discussion 1175-1166).
24. Zeissig S., Burgel N., Gunzel D., Richter J., Mankertz J., Wahnschaffe U., Kroesen A.J., Zeitz M., Fromm M., Schulzke J.D. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007, 56:61-72.
25. Burgel N., Bojarski C., Mankertz J., Zeitz M., Fromm M., Schulzke J.D. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002, 123:433-443.
26. Ralay Ranaivo H., Carusio N., Wangensteen R., Ohlmann P., Loichot C., Tesse A., Chalupsky K., Lobysheva I., Haiech J., Watterson D.M., Andriantsitohaina R. Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice. Am. J. Pathol. 2007, 170:439-446.
27. Shen L., Black E.D., Witkowski E.D., Lencer W.I., Guerriero V., Schneeberger E.E., Turner J.R. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J. Cell Sci. 2006, 119:2095-2106.
28. Pritts T.A., Moon R., Fischer J.E., Salzman A.L., Hasselgren P.O. Nuclear factor-kappaB is activated in intestinal mucosa during endotoxemia. Arch. Surg. 1998, 133:1311-1315.
29. Ma T.Y., Boivin M.A., Ye D., Pedram A., Said H.M. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G422-G430.
30. Al-Sadi R., Ye D., Dokladny K., Ma T.Y. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J. Immunol. 2008, 180:5653-5661.
31. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.